The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHG.L Regulatory News (GHG)

  • There is currently no data for GHG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GHG hosts Investor Day in Tbilisi

26 Jun 2019 07:00

RNS Number : 4140D
Georgia Healthcare Group PLC
26 June 2019
 

  Tbilisi, 26 June 2019

 

Georgia Healthcare Group hosts Investor Day in Tbilisi 

 

Georgia Healthcare Group PLC ("GHG" or the "Group"), the only fully integrated healthcare provider in the Caucasus region, is today hosting an Investor Day for analysts and investors in Tbilisi on Wednesday 26th June 2019.

 

As part of the presentations, GHG will update investors on its next 5-year strategic goals which are summarised below. Strategically, the Group will seek to:

· continue to focus on building its presence throughout the Georgian healthcare ecosystem

· manage its customers more effectively on a fully integrated basis

· improve operational performance through: increased utilisation of existing facilities; increased efficiency by automatization of service processes and full roll-out of health information system; and utilise digitalisation to develop a fully integrated healthcare platform

· substantially improve free cash flow generation through delivering: higher earnings, with reduced capital requirements and lower interest expense, and

· developing a pipeline of new market growth portfolios: over the next 5 years to generate potential incremental EBITDA of c.GEL 50 million, from a total initial investment of c.GEL40-50 million

 

This strategy will be implemented by:

· completing the successful launch and roll-out of the Group's two flagship hospitals

· improving medical service quality, and filling existing service gaps

· developing service exports to foreign patients (medical tourism)

· increasing the number of polyclinics and registered patients

· further expanding Georgia's largest retail pharmacy chain

· completing the recent transformation of the medical insurance business, and

· leveraging the recent launch of the largest multi-disciplinary laboratory in the region

 

From a financial and capital strategy perspective, the Group will discuss the following key metrics:

· investing in new opportunities - already revenue generating assets that deliver a 20%+ marginal Return on Invested Capital (ROIC)

· reducing expected capital expenditures to c.GEL 35 million per annum over the next few years

· enabling, where possible and appropriate, the buyout of existing minority interests

· managing the Group's balance sheet, on an ongoing basis, at an average less than 2.0 times net debt to EBITDA from the end of 2020

· maintaining the Group's recently adopted dividend policy: 20-30% of annual profit attributable to shareholders to be distributed as dividends

· to target an 80%+ EBITDA to cash conversion ratio

· to further improve the Group's cost of funding, and to reduce interest expense

Over the next 5 years, GHG will seek to achieve double-digit compound annual revenue growth; and mid-teens compound annual EBITDA growth. In doing so, this is expected to support the delivery of c.15-17% ROIC.

 

A full set of the presentation slides can be viewed on the GHG website at ghg.com.ge

 

 

 

Name of authorised official of issuer responsible for making notification:

Ketevan Kalandarishvili, Head of Investor Relations

 

 

About Georgia Healthcare Group PLC

Georgia Healthcare Group PLC is a UK incorporated holding company of the largest healthcare services provider in the fast-growing, predominantly privately-owned, Georgian healthcare services market. GHG's leadership position is underpinned by offering the most comprehensive range of inpatient and outpatient services targeting the mass market segment through its vertically integrated network of 18 hospitals and 35 clinics. GHG is the single largest market participant, accounting for 25% of total hospital bed capacity in the country, as of 31 March 2019. GHG is also the largest pharmaceuticals retailer and wholesaler in Georgia, with approximately 30% market share by revenue. GHG is the second largest provider of medical insurance in Georgia with a 27% market share based on net insurance premiums earned and approximately c.230,000 insurance customers as of now. GHG employed a total of c.16,092 people as at 31 March 2019, including c.3,600 physicians and 3,300 pharmacists.

 

For further information, please visit ghg.com.ge or contact: 

Nikoloz Gamkrelidze

Irakli Gogia

Ketevan Kalandarishvili

CEO

CFO

Head of Investor Relations

+995 322 550505 (5077)

+995 322 550505 (5088)

+995 322 550505 (5079)

ngamkrelidze@ghg.com.ge

irakligogia@ghg.com.ge

ir@ghg.com.ge

 

 

This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUVSRRKSANUUR
Date   Source Headline
23rd Aug 20187:30 amRNSUpdate on Georgia Capital's holding in GHG
15th Aug 20187:00 amRNSHalf-year Report
9th Aug 20187:00 amRNSNotice of Results
25th Jul 20184:35 pmRNSPrice Monitoring Extension
23rd Jul 20184:41 pmRNSSecond Price Monitoring Extn
23rd Jul 20184:35 pmRNSPrice Monitoring Extension
12th Jul 20187:00 amRNSGHG has launched a new Home Care service
2nd Jul 201812:26 pmRNSDirector/PDMR Shareholding
28th Jun 20185:02 pmRNSDirector/PDMR Shareholding
21st Jun 20183:13 pmRNSDirector/PDMR Shareholding
20th Jun 20185:00 pmRNSDirector/PDMR Shareholding
15th Jun 201811:57 amRNSDirector/PDMR Shareholding
12th Jun 20182:56 pmRNSDirector/PDMR Shareholding
6th Jun 20185:20 pmRNSDirector/PDMR Shareholding
29th May 20188:43 amRNSHolding(s) in Company
24th May 201812:04 pmRNSDirector/PDMR Shareholding
17th May 201810:18 amRNSDirector/PDMR Shareholding
15th May 20187:03 amRNS1st Quarter Results
11th May 20187:00 amRNSNotice of Results
30th Apr 20181:23 pmRNSResult of AGM
23rd Apr 20184:35 pmRNSPrice Monitoring Extension
20th Apr 20184:40 pmRNSSecond Price Monitoring Extn
20th Apr 20184:35 pmRNSPrice Monitoring Extension
29th Mar 20184:42 pmRNSDirector/PDMR Shareholding
26th Mar 20184:37 pmRNSNotice of AGM
26th Mar 20182:12 pmRNSDirector/PDMR Shareholding
19th Mar 20184:35 pmRNSPrice Monitoring Extension
19th Mar 201812:04 pmRNSDirector/PDMR Shareholding
15th Mar 201812:15 pmRNSDirector/PDMR Shareholding
12th Mar 20182:07 pmRNSDirector/PDMR Shareholding
8th Mar 20187:30 amRNSDirector/PDMR Shareholding
8th Mar 20187:00 amRNSGHG launches a new district polyclinic in Tbilisi
7th Mar 20187:00 amRNSAnnual Financial Report
5th Mar 20187:30 amRNSDirector/PDMR Shareholding
2nd Mar 20187:30 amRNSDirector/PDMR Shareholding
27th Feb 20187:30 amRNSDirector/PDMR Shareholding
23rd Feb 20185:43 pmRNSDirector/PDMR Shareholding
23rd Feb 20187:30 amRNSDirector/PDMR Shareholding
15th Feb 20187:00 amRNSFinal Results
12th Feb 20187:00 amRNSNotice of Results
26th Jan 20187:00 amRNSAcquisition of a new medical insurance client
27th Dec 20177:00 amRNSGHG acquired a district Polyclinic in Tbilisi
5th Dec 20174:40 pmRNSSecond Price Monitoring Extn
5th Dec 20174:35 pmRNSPrice Monitoring Extension
9th Nov 20175:00 pmRNSGHG hosts Investor Day in Tbilisi
9th Nov 20177:00 amRNSGHG acquired a district Polyclinic in Tbilisi
8th Nov 20177:00 amRNS3rd Quarter Results
6th Nov 20177:00 amRNSNotice of Results
3rd Nov 20174:35 pmRNSPrice Monitoring Extension
3rd Nov 20177:00 amRNSGHG launches an oncology inpatient department

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.